All Q4 FY25 results →
FC

Fineotex Chemical Ltd

Q4 FY25Chemicals & Petrochemicals

Fineotex Chemical Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹47
Market cap₹4.5K Cr
P/E36.8
Updated23 Aug 2026
Read4 min read

The short version

Company confident of sustaining past growth trends, targeting continued strong performance similar to last five years with CAGR around 22-28% in earnings per share. The company aims to continue the strong growth trend of the last five years, targeting sustained EBITDA margins around 24%.

From Fineotex Chemical Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Company confident of sustaining past growth trends, targeting continued strong performance similar to last five years with CAGR around 22-28% in earnings per share. (Page 14-15)
  • Organic expansion ongoing with Rs. 115 crores already invested; Rs. 355 crores in liquid cash available for further expansion including new capacity additions. (Page 15-16)
  • Textile segment volumes increased ~15% in FY '25, revenue grew ~10%, indicating strong growth in core segment. (Page 10)
  • Oil and gas segment showing significant opportunity with major global clients engaging; fungible capacity allows quick scale-up with modest CAPEX of Rs. 20-30 crores anticipated for powders or specific product lines. (Page 14-15)

2 more points from Fineotex Chemical Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Fineotex Chemical Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The company has invested approximately Rs. 110-115 crores in organic expansion over the last 15 months.
  • A new greenfield plant is being set up in Ambarnath, expected to commence operations by Q2 FY 2026, adding 15,000 metric tonnes per annum capacity, bringing total capacity to 1,20,000 metric tonnes.
  • The company raised Rs. 342 crores recently through fundraising; promoters contributed Rs. 44 crores.
  • Capital is tied up in capital work in progress, including the new Ambarnath facility and a new corporate office in Andheri.
  • Strategic focus includes investments in R&D, new product developments (e.g., AquaStrike Premium – biotechnology-based mosquito control), and expanding into water treatment and oil & gas chemical segments.

2 more points from Fineotex Chemical Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Fineotex Chemical Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company has a healthy order book reflecting strong business performance and customer trust.
  • Certain deliveries were postponed during Q4 FY '25 due to market and external conditions but are expected to be fulfilled in the current financial year.
  • There is a strong pipeline of inquiries, especially in the oil and gas sector, with significant international interest due to supply chain diversification from China to India.
  • The management highlighted exciting orders and contracts secured recently, particularly from large global oil and gas companies.

2 more points from Fineotex Chemical Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Fineotex Chemical Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹314 Cr, net profit ₹44 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Atul (Q4 FY25)

    Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…

  • Vidhi Specialty Food Ingredients Ltd (Q4 FY25)

    109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…

  • Chemcon Speciality Chemicals Ltd (Q4 FY25)

    54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Valiant Organics (Q4 FY25)

    Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Fineotex Chemical Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Fineotex Chemical Ltd Q4 FY25 results?

Company confident of sustaining past growth trends, targeting continued strong performance similar to last five years with CAGR around 22-28% in earnings per share. The company aims to continue the strong growth trend of the last five years, targeting sustained EBITDA margins around 24%.

What is Fineotex Chemical Ltd share price analysis?

Fineotex Chemical Ltd currently shows a neutral. The stock trades at a P/E of 36.8 with a market cap of ₹4,501 Cr. Investors should review the full earnings analysis for detailed insights.

Is Fineotex Chemical Ltd planning capital expenditure?

The company has invested approximately Rs.

Keep Fineotex Chemical Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.